Bionic Eye Implants for Macular Degeneration

Age-related macular degeneration, or AMD, remains a leading cause of vision loss for people over 60. Until recently, losing central vision to the “dry” form of this disease was considered irreversible. However, new developments with the Prima System have shifted this narrative. This bionic vision system is currently showing significant success in restoring partial sight to patients who had previously lost their ability to read or recognize faces.

Understanding the Prima Vision System

The specific technology making headlines is the Prima System. Originally developed by the French company Pixium Vision and recently acquired by Science Corp, this device differs significantly from older bionic eyes like the Argus II.

The Prima System focuses specifically on patients with atrophic dry age-related macular degeneration. This condition destroys the photoreceptors in the center of the retina but leaves the rest of the eye’s neural network relatively intact. The Prima implant takes over the job of these damaged photoreceptors.

The Hardware Components

The system relies on three specific components working in unison:

1. The Wireless Implant: A tiny, photovoltaic chip measuring just 2 millimeters by 2 millimeters. Surgeons place this subretinal chip underneath the macula at the back of the eye.
2. Specialized Glasses: These look like standard sunglasses but contain a miniature camera and a digital projector.
3. Pocket Processor: A small computer worn by the patient that processes the visual data.

How the Technology Restores Sight

The process of seeing with the Prima System is a blend of biology and digital engineering. It begins when the camera on the glasses captures a scene. The pocket processor simplifies this image and extracts the most relevant information.

The glasses then project this processed data as a beam of near-infrared light directly into the eye through the pupil. This light strikes the photovoltaic chip implanted under the retina. The chip acts like a tiny solar panel. It converts the light energy into electrical impulses.

These electrical impulses stimulate the remaining bipolar cells in the retina. The signal then travels down the optic nerve to the brain, just like natural vision. The brain interprets these signals as visual patterns. Because the implant is wireless and powered by light, there are no wires penetrating the eye wall, which reduces surgical risk compared to earlier technologies.

Clinical Trial Results and Success Stories

The excitement surrounding this technology stems from the PRIMAvera clinical trial and earlier feasibility studies. The results offer concrete hope rather than theoretical possibilities.

Patients involved in these trials suffer from Geographic Atrophy, an advanced form of dry AMD. Before the implant, many could not identify letters or objects in their central field of vision. After implantation and rehabilitation, participants demonstrated the ability to:

• Identify sequences of letters.
• Recognize numbers.
• Read short sentences.

One specific advantage of the Prima System is the “zoom” feature. Patients can use the glasses to digitally magnify images. This allows them to read smaller print or see details that the resolution of the chip alone might not capture. While the vision is not “natural” (it is often described as pixelated or monochromatic), it provides functional utility that restores independence.

Science Corp and the Future of the Tech

In 2024, Science Corp, a brain-computer interface company founded by Neuralink co-founder Max Hodak, acquired the assets of Pixium Vision. This acquisition is significant. It brings substantial financial resources and engineering expertise to the development of the Prima implant.

Science Corp is pushing to bring this technology to the commercial market. The company aims to refine the resolution of the implant, potentially increasing the number of pixels on the chip to provide sharper images. While Neuralink focuses on cortical implants (putting chips directly in the brain), the Prima System’s retinal approach is less invasive and utilizes the eye’s existing biology.

Who Is Eligible for This Procedure?

Not everyone with vision loss qualifies for this specific bionic eye. The Prima System is designed strictly for Atrophic Dry AMD.

To be a candidate, a patient generally must meet these criteria:

• Intact Optic Nerve: The pathway from the eye to the brain must be healthy.
• Peripheral Vision: The patient usually retains some side vision, as the implant only replaces the central vision.
• Previous Vision: The patient must have had sight previously (the brain needs to know how to process visual signals).

This technology is not currently suitable for those blinded by glaucoma or diabetic retinopathy, as those conditions often damage the optic nerve or the retina in ways that prevent the chip from communicating with the brain.

Frequently Asked Questions

Is the Prima System available for purchase now? As of late 2024, the device is an investigational device. It is currently moving through regulatory approval processes in Europe (CE Mark) and the United States (FDA). It is not yet commercially available for general prescription.

Does the surgery hurt? The implantation is a surgical procedure performed under anesthesia. While the surgery itself is not felt, there is a standard recovery period involving eye drops and follow-up visits. It is minimally invasive compared to older bionic eye surgeries because it involves no wires passing through the eye wall.

What is the cost of the bionic eye? Pricing has not been officially released for the commercial market. However, similar neuro-stimulation devices and gene therapies often range from $100,000 to over $400,000. Coverage by insurance and Medicare will be a critical factor in patient access once the device is approved.

Will I see in color? Currently, the vision provided by the Prima implant is not in full color. Patients typically perceive patterns of light, often described as white or yellowish flashes against a dark background. The brain learns to interpret these flashes as shapes and objects over time.